91 Startups
  • Sector
  • Participated in
  • Year of participation

T-Cell Factory

  • 2013
  • Enabling Technology
  • Therapeutics
  • Venture Challenge
T Cell Factory (TCF) will identify and develop therapeutic T cell receptor (TCR) genes for the growing market of cancer therapies.

TargED Biopharmaceuticals

  • 2018
  • Therapeutics
  • Venture Challenge
We at TargED have developed MICROLYSE, an innovative fusion-protein that has an antibody domain that recognizes microthrombi and an enzymatic domain that breaks them down.

thromboDX

  • 2011
  • Diagnostics
  • Other
thromboDx BV is a molecular diagnostics company that develops and commercialises blood-based diagnostics through its proprietary platelet-powered technology platform

Toxys

  • 2013
  • Enabling Technology
  • Other
  • Value Centre
  • Venture Challenge
At Toxys we strongly believe in bringing high quality information to our partners and clients. I strongly believe that the future for human safety assessment is not with simple tests that only provide a yes or no answers, but advanced in vitro models that provide reliable and relevant insight into the mechanism of action of novel chemicals and materials. We are committed to support our partners in understanding their latest compounds and in making the right decisions during R&D of novel products

TropIQ Health Sciences

  • 2012
  • Other
  • Therapeutics
TropIQ Health Sciences accelerates the discovery and development of drugs against malaria.

TubaScan

  • 2011
  • Diagnostics
  • Other
TubaSCAN for Chlamydia trachomatis associated infertility and tubal pathology based on host genetic markers.

Ubiq

  • 2009
  • Enabling Technology
  • Other
drug discovery in the ubiquitin field

UFO Biosciences

  • 2019
  • Enabling Technology
  • Venture Challenge
Targeting the cells that matter, enabling better cancer care. By identifying, selecting and isolating single cells, UFO Biosciences enables the identification of the important genes that are missed with current technology.

UpyTher

  • 2017
  • Therapeutics
  • Venture Challenge
UPyTher’s mission is to provide custom drug delivery solutions that enable sustained localized administration of therapeutics.

X-heal Diagnostics

  • 2017
  • Diagnostics
  • Venture Challenge
The ambition of X-Heal Diagnostics is to improve lung health through fast, specific and non-invasive diagnosis of lung infections in different patient groups including chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and tuberculosis patients.